Siemens Healthineers and Greenville, S.C.-based Prisma Health are expanding their Value Partnership1 to help elevate the standard of cancer care in South Carolina and Tennessee.
Prisma Health鈥檚 $50 million investment includes the acquisition of the Ethos adaptive radiotherapy system from Varian, a Siemens Healthineers company. Adaptive radiotherapy provides cancer patients with more precise and personalized care through AI-driven treatment and planning processes that adapt to tumor and anatomical changes in real time to protect healthy tissue.
In 2021, Siemens Healthineers and Prisma Health entered into a 10-year Value Partnership to improve care, promote innovation, and develop the local workforce. The expanded relationship will integrate next-generation technology and specialized clinical oncology and professional services, new tools and time-saving workflows. The goal of the Value Partnership is to advance more personalized, efficient, and accessible care for the communities Prisma Health serves.
鈥淪ince entering into the Value Partnership with Siemens Healthineers, Prisma Health has expanded access to imaging services and introduced new technologies and care locations to better serve our communities,鈥 said Clarence Sevillian, executive vice president and chief operating officer of Prisma Health. 鈥淥ur priority is ensuring that patients have access to care that is both compassionate and informed by the latest clinical insights. This next phase of the partnership reflects a continued spirit of collaboration, integrating advanced oncology tools and support services that may help streamline operations and enhance the patient experience.鈥
Added John Kowal, president and head of the Americas at Siemens Healthineers: 鈥淲orking with Prisma Health to establish a full continuum of cancer care鈥攆rom screening and diagnosis through survivorship鈥攊s an enormous point of pride for our organization. Combining the power of diagnostic imaging, radiation therapy, and post-treatment monitoring with professional services to manage complex oncology operations helps to ensure that advances in patient care are consistent and sustainable over time.鈥
Media contact
Julie Gibson
Phone: (917) 929-5779
Email: julie.gibson@siemens-healthineers.com
Visit the聽Siemens Healthineers Press Center.
Subscribe to our .
Media contact
Tammie Epps
Phone: (803) 318-1598
Email: news@prismahealth.org
Siemens Healthineers聽pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around 鈧22.4 billion. Further information is available at .
